Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Pyrazinamide (500mg) Tablet
Therapeutic Category
Pulmonary, Respiratory, Antibacterials, Antibiotic
Dosage Form
Tablet
Packaging Type
Blister
Packaging
10*10
Price
₹1/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Pyrinide 500 Tablet contains Pyrazinamide 500 mg, a first-line anti-tubercular agent used to treat active tuberculosis infections. It works by inhibiting mycobacterial fatty acid synthesis, effectively reducing bacterial growth and supporting combination therapy regimens.
Pyrazinamide is primarily used during the initial intensive phase of TB treatment along with Isoniazid, Rifampicin, and Ethambutol. Its role is critical in shortening treatment duration and ensuring effective bacterial eradication.
Belonging to the anti-infective and pulmonology segment, Pyrinide 500 Tablet is in high demand among hospitals, clinics, and government TB programs. Its consistent prescription trend makes it a valuable B2B product.
For PCD pharma franchise partners, third-party manufacturers, and exporters, Pyrinide 500 Tablet provides a profitable business opportunity. Its inclusion in standard TB therapy ensures recurring demand and a strong market presence across India.
Common side effects may include nausea, vomiting, loss of appetite, and mild joint pains. Rarely, it may cause liver toxicity, gout, or allergic skin reactions. Contact your doctor immediately if you experience yellowing of eyes or skin, severe fatigue, or swelling.
Pyrinide 500 Tablet is indicated for the treatment of active tuberculosis, usually in combination with other first-line anti-TB medications such as Isoniazid and Rifampicin. It helps in reducing bacterial load and preventing disease progression.
Take Pyrinide 500 Tablet exactly as prescribed, preferably on an empty stomach. Avoid alcohol while on treatment due to risk of liver damage. Regular monitoring of liver function and uric acid levels is recommended. Do not discontinue therapy without consulting your healthcare provider.
Store Pyrinide 500 Tablet in a cool, dry place below 25°C, away from direct sunlight and moisture. Keep out of reach of children.
Composition : Glycopyrrolate (25mcg) Respule
Composition : Budesonide (0.5mg) Respule
Composition : Levosalbutamol (1.25mg) + Ipratropium (500mcg)
Composition : Terbutaline (1.25mg/5ml) + Acebrophylline (50mg/5ml) + Guaifenesin (50mg/5ml) Syrup
Composition : Acetylcysteine (600mg) effervescent
Composition : Salmeterol (25mcg) + Fluticasone Propionate (250mcg)
Composition : Acebrophylline (100mg) Capsule
Composition : Xylometazoline (0.1% w/v)
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Pyrazinamide IP 500mg Tablet has consistent demand in the anti-infective, respiratory care, and tuberculosis (TB) management segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on specialty infectious disease portfolios.
Medical distributors and agencies can benefit from demand for tuberculosis management under specialist medical supervision. Pyrazinamide IP 500mg is an antitubercular medication used as part of combination therapy for tuberculosis treatment Commonly prescribed for the management of active tuberculosis (TB) as advised by healthcare professionals and national treatment guidelines Plays a vital role in multidrug anti-tuberculosis treatment regimens, helping improve treatment effectiveness and support successful patient outcomes Provides a commonly used dosage strength that allows flexible dose adjustment according to patient requirements and treatment protocols Oral tablet formulation offers convenient administration as part of prescribed combination therapy Requires regular monitoring of liver function and overall treatment response during treatment Frequently utilized in chest clinics, pulmonary care centers, hospitals, TB treatment programs, and infectious disease departments Widely prescribed by pulmonologists, infectious disease specialists, and general physicians involved in tuberculosis care This strengthens a comprehensive anti-infective and tuberculosis care portfolio.
Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Pyrazinamide IP 500mg Tablet with promotional support, monopoly rights, attractive packaging, and competitive pricing for distributors and wholesalers.
Wholesalers and medical agencies benefit from consistent institutional demand, government and private healthcare procurement opportunities, reliable supply chain support, repeat purchases, and attractive margins in the anti-infective segment.
Interested distributors, stockists, and wholesalers can partner with Cafoli LifeCare Pvt Ltd to access lucrative PCD pharma franchise opportunities across India. With exclusive monopoly rights, extensive promotional support, high-quality pharmaceutical products, attractive business margins, and dependable logistics support, Cafoli LifeCare Pvt Ltd helps franchise partners build a successful and profitable pharmaceutical business.